ABSTRACT Indirect immunofluorescence of certain human sera demonstrated an antigen(s) in the cytoplasm of 1-5% of the cells of a T-cell line, MT-1, from a patient with adult T-cell leukemia (ATh), which is endemic in southwestern Japan. The antigen was not detected in other human lymphoid cell lines, including six T-cell lines, seven B-cell lines, and four non-T non-B cell lines. The antigen did not show cross antigenicity with that of herpesviruses, including Epstein-Barr virus, herpes simplex virus, cytomegalovirus, varicella-zoster virus, herpesvirus saimiri, and Marek disease virus. The proportion of antigen-bearing cells was increased by a factor of =5 on culture in the presence of 5-iodo-2'-deoxyuridine. Antibodies against the antigen in MT-I cells were found in all 44 patients with ATL examined and in 32 of 40 patients with malignant T-cell lymphomas (most of them had diseases similar to ATL except that leukemic cells were not found in the peripheral blood). The antibodies were also detected in 26% of the healthy adults examined from ATL-endemic areas but in only a few of those examined from ATL-non-endemic areas. On electron microscopy, extracellular type C virus particles were detected in pelleted MT-I cells cultured in the presence of5-iodo-2'-deoxyuridine. Recently, a probably new disease entity, adult T-cell leukemia (ATL), was proposed by Takatsuki and his co-workers (1, 2). Since then, many patients having ATL have been reported. These patients have been reported from a restricted area of southwestern Japan (3-7). This malignant disease has also been called adult T-cell leukemia/lymphoma (ATLL) because of its leukemic lymphoma nature. Its characteristic clinical and hematological features are: (i) onset in adulthood; (ii) acute or chronic leukemia with rapid progression; (iii) resistance to treatment with current antileukemic agents; (iv) appearance in peripheral blood of pleomorphic leukemic cells that have markedly deformed nuclei and T-cell surface markers; (v) frequent accompaniment by lymphadenopathy, hepatosplenomegaly, and hypercalcemia; (vi) absence of mediastinal tumor; and (vii) frequent skin lesions such as erythroderma and nodule formation (1) (2) (3) (4) (5) 8) .
and Marek disease virus. The proportion of antigen-bearing cells was increased by a factor of =5 on culture in the presence of 5-iodo-2'-deoxyuridine. Antibodies against the antigen in MT-I cells were found in all 44 patients with ATL examined and in 32 of 40 patients with malignant T-cell lymphomas (most of them had diseases similar to ATL except that leukemic cells were not found in the peripheral blood). The antibodies were also detected in 26% of the healthy adults examined from ATL-endemic areas but in only a few of those examined from ATL-non-endemic areas. On electron microscopy, extracellular type C virus particles were detected in pelleted MT-I cells cultured in the presence of5-iodo-2'-deoxyuridine. Recently, a probably new disease entity, adult T-cell leukemia (ATL), was proposed by Takatsuki and his co-workers (1, 2) . Since then, many patients having ATL have been reported. These patients have been reported from a restricted area of southwestern Japan (3) (4) (5) (6) (7) . This malignant disease has also been called adult T-cell leukemia/lymphoma (ATLL) because of its leukemic lymphoma nature. Its characteristic clinical and hematological features are: (i) onset in adulthood; (ii) acute or chronic leukemia with rapid progression; (iii) resistance to treatment with current antileukemic agents; (iv) appearance in peripheral blood of pleomorphic leukemic cells that have markedly deformed nuclei and T-cell surface markers; (v) frequent accompaniment by lymphadenopathy, hepatosplenomegaly, and hypercalcemia; (vi) absence of mediastinal tumor; and (vii) frequent skin lesions such as erythroderma and nodule formation (1) (2) (3) (4) (5) 8) .
While studying the viral etiology ofthis malignancy, we found an antigen associated with a long-term cultured ATL cell line that is reactive with the sera of all the ATL patients tested and also with the sera of >25% ofhealthy adults from ATL-endemic areas but not with sera from those from nonendemic areas. We also detected type C virus persons. The results of this screening test can be summarized as showing that a considerable proportion (10-30%) of adults living in ATL-endemic areas had antibody to ATLA and that most, if not all, patients having ATLL had anti-ATLA, whereas only a few of the adults from ATL-non-endemic areas had the antibody.
The anti-ATLA titers of selected sera (>1:10 dilution) from 10 ATL patients and 10 healthy adults ranged from 1:20 to 1:640 (data not shown). There seemed to be no significant differences in the titers of ATL patients and healthy adults, although the number of sera tested so far is limited.
Detection of Type C Virus in MT-i Cells. As the above findings suggest that the ATLA may be related to an RNA tumor virus, we next examined MT-1 cells for virus particles by electron microscopy. The cells were cultured in medium containing A, typical ATL; B, various types of T-cell malignant lymphomas other than ATL; C, undefined and unclassified cell-type lymphoma and leukemia, B-cell lymphoma and leukemia, Hodgkin disease, Lennert lymphoma, immunoblastic lymphadenopathy, and common acute lymphatic leukemia; D, acute or chronic myelocytic, monocytic, and myelomonocytic leukemia and erythroleukemia; E, hypertension, rheumatoid arthritis, and systemic lupus erythematosus; F 50 resi-Medical Sciences: Hinuma et aL IdUrd at 50 gg/ml for 3 days, and then thin sections of cell pellets were examined by electron microscopy as described (10) . Type C virus particles were observed (Fig. 3) . No intracellular particles were detected; most particles were present as immature or mature extracellular virions. The virion shape and the presence of centrally located nucleoids in mature particles suggest that the virus is type C, not type B or type D. Although very infrequent, type C virus particles were'also detected in association with cells cultured in the absence of IdUrd. So far, we have not encountered typical budding and completely electron-lucent forms of the type C particles.
DISCUSSION
The present paper reports a study of the possible viral etiology of ATL in Japan. Although the data re preliminary, three main points may be argued.
(i) Did the immunofluoresence study detect antibodies directed against the antigen specifically associated with ATL leukemic cells? Several findings support this possibility. The ATLA demonstrated was found in the MT-1 cell line, which was derived from a patient having ATL, but not in any of the other human lymphoid cell lines tested, including T-cell, B-cell, and null cell lines ( Table 1 ). The MT-1 cell-line has the same characteristics as ATL leukemic cells in vivo (9, 10) , which are difProc. NatL Acad. Sci. USA 78 (1981) 6479 ferent from those ofother T-cell lines. Furthermore, in separate experiments (unpublished data), we detected ATLA in five other ATL cell lines established recently. As shown in Table 3 , the sera of all ATL patients tested gave a positive reaction for anti-ATLA. Moreover, most of the patients having adult malignant T-cell lymphoma, which is distinguishable from ATL only by the fact that neoplastic T cells do not appear in the peripheral blood, also had anti-ATLA. On the other hand, the incidence of anti-ATLA was no higher in patients having other malignancies than in healthy adults from the ATL-endemic area. This suggests that ATLA and anti-ATLA are associated with ATL but not with other malignancies.
-(ii) Is the ATLA detected by the immunofluorescence test related to the type C virus particles detectable by electron microscopy? The following evidence suggests that ATLA could be related to the type C virus: (a) the remarkable induction of ATLA by IdUrd (23) 14 "'
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. T, -Wi..' N goides). However, we did not find anti-ATLA in three patients having mycosis fungoides (unpublished), suggesting a difference between ATLA and putative antigens of the type C retrovirus associated with mycosis fungoides, which is known to have a worldwide distribution. The type C virus in the MT-1 cells in our studies was probably not a contaminant due to infection as we have not used any type of retrovirus at least since studies on the MT-1 cell culture started. These facts suggest a possible association of ATLA with a type C virus antigen in the cells. However, these points provide only indirect evidence, and direct proof is needed for the identification of the stainable cells with those carrying virus particles.
(iii) Do the patterns of the incidence of anti-ATLA in serum donors in either ATL-endemic or ATL-non-endemic areas give any information concerning the etiology and epidemiology of ATL or ATLL? It was a notable finding that >25% ofthe healthy adults tested in the ATL-endemic area and anti-ATLA but scarcely any healthy adults in ATL-non-endemic areas had the antibody. In general, such a pattern indicates the presence of some agent(s) or factor(s) affecting the residents in a certain area but not those in other areas. The agent(s) or factor(s) responsible for development ofthe anti-ATLA can be assumed to be a virus. Hence, the type C virus found in cultured MT-1 ATL cells is the most probable candidate virus for the antibody to ATLA, and the ATLA is possibly a virus-associated antigen.
The present results suggest, but do not prove a causal relationship between a type C virus and ATL.
We 
